PROSPECTIVE STUDY FOR VALIDATION OF A SINGLE PROTOCOL FOR THE 13C-UREA BREATH TEST USING TWO DIFFERENT DEVICES IN THE DIAGNOSIS OF H. PYLORI INFECTION
- PMID: 31460586
- DOI: 10.1590/S0004-2803.201900000-38
PROSPECTIVE STUDY FOR VALIDATION OF A SINGLE PROTOCOL FOR THE 13C-UREA BREATH TEST USING TWO DIFFERENT DEVICES IN THE DIAGNOSIS OF H. PYLORI INFECTION
Abstract
Background: 13C-urea breath test (UBT) is the gold-standard, noninvasive method for H. pylori diagnosis. However, there is no uniform standardization of the test. This situation can be unpractical for laboratories running with two or more devices.
Objective: To perform a prospective comparison validation study of UBT employing one validated protocol for two different devices: BreathID Hp Lab System® (Exalenz Bioscience Ltd, Israel), here called device A and IRIS-Doc2® (Wagner Analysen-Technik, Germany, now Mayoly Spindler Group, France), here called device B, in the diagnosis of H. pylori infection.
Methods: A total of 518 consecutive patients (365 females, 153 males, mean age 53 years) referred for UBT were included. All patients received device A protocol as follow: after at least one hour fasting, patients filled two bags prior to the test, then ingested an aqueous solution containing 75 mg of 13C-urea with a 4.0 g citric acid powder and filled another two bags 15 min after ingesting the test solution. One pair of breath sample bags (before and after ingestion) was analyzed by the two different devices. A delta over baseline (DOB) ≥5‰ indicated H. pylori infection. Statistics: Wilcoxon test, kappa coefficient with 95% CI, Wilson's method.
Results: Considering the device A protocol as the gold standard, its comparison with device B showed a sensitivity of 99.3% (95% CI: 96.3-99.9) and a specificity of 98.9% (95% CI: 97.3-99.6). Kappa coefficient was 0.976 (95% IC: 0.956-0.997).
Conclusion: Correlation between the two devices was excellent and supports a uniform standardization of UBT.
Similar articles
-
A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection.Gut. 1997 Apr;40(4):459-62. doi: 10.1136/gut.40.4.459. Gut. 1997. PMID: 9176071 Free PMC article.
-
Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting.Am J Gastroenterol. 1999 Aug;94(8):2100-4. doi: 10.1111/j.1572-0241.1999.01284.x. Am J Gastroenterol. 1999. PMID: 10445534
-
13C-urea breath test for the diagnosis of Helicobacter pylori infection: are basal samples necessary?Eur J Gastroenterol Hepatol. 2000 Nov;12(11):1201-5. doi: 10.1097/00042737-200012110-00006. Eur J Gastroenterol Hepatol. 2000. PMID: 11111776
-
Urea breath test: a diagnostic tool in the management of Helicobacter pylori-related gastrointestinal diseases.Acta Gastroenterol Belg. 1998 Jul-Sep;61(3):332-5. Acta Gastroenterol Belg. 1998. PMID: 9795467 Review.
-
Urea breath tests in the management of Helicobacter pylori infection.Gut. 1998 Jul;43 Suppl 1(Suppl 1):S47-50. doi: 10.1136/gut.43.2008.s47. Gut. 1998. PMID: 9764040 Free PMC article. Review.
Cited by
-
What Is New in Helicobacter pylori Diagnosis. An Overview.J Clin Med. 2021 May 13;10(10):2091. doi: 10.3390/jcm10102091. J Clin Med. 2021. PMID: 34068062 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous